Novartis Announces Acquisition of German Biotech Firm MorphoSys
by Novartis, the Swiss pharmaceutical giant, has recently revealed its plans to acquire the German biotech company MorphoSys. The deal, which is valued at 2.7 billion …
NewsStatix.com – Navigating the Pulse of Diverse Industries